ANI
26 May 2023, 20:55 GMT+10
New Delhi [India], May 26 (ANI) Elon Musk's firm Neuralink on Friday said it received US Food and Drug Administration (FDA)'s approval for conducting its first test on humans.
In a tweet, Neuralink expressed its excitement, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people."The firm added, "Recruitment is not yet open for our clinical trial. We'll announce more information on this soon!." This approval is seen as a crucial step forward for Neuralink's groundbreaking technology.
Neuralink, acquired by Musk, describes the technique where a sewing machine-like robot implants ultrathin threads deep into the brain, according to The New York Times reports.
Neuralink said that currently, the insertion of wiring requires surgeons to drill holes through the skull. In the future, they hope to use a laser beam to pierce the skull for minimal sensation and pain.
Electric car firm Telsa's Chief Executive Officer Elon Musk had previously explained that the implantable Neuralink device would enable individuals to interact with computers using their minds.
Musk during a presentation had earlier claimed that the implant could make computer control possible for people with paralysis outside of a lab setting. Neuralink's engineering work is an important advance, he added, but the results shown by the company were not as important.
The presentation focused on the "Link" device, which resembles an inch-wide stack of several coins with hundreds of hair-thin threads, according to the New York Times.
A surgical robot would cut a hole in the skull and slip the electrode threads into the gray matter of the brain, according to Musk's 2020 company presentation. The coin-like piece would sit flush with the skull, NYT said.
According to NYT, while the potential use cases are plenty, Musk's idea behind the ambitious system is medical use, such as helping amputees regain mobility or helping people hear, speak, or see. (ANI)
Get a daily dose of Iran Herald news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Iran Herald.
More InformationNEW DELHI, India: Indian federal police documents indicate that the country has filed a graft case against the UK's BAE ...
NEW YORK, New York - U.S. stocks rallied sharply on Thursday after the House of Representatives passed the controversial bill ...
SANTA CLARA, California: Nvidia Corp, the world's most valuable listed chip company, said that to meet soaring customer demand for ...
BURBANK, California: Over the US Memorial Day weekend, Disney's live-action remake of its 1989 animated classic, "The Little Mermaid," brought ...
NEW YORK CITY, New York: The Nielsen company said that CBS has again claimed the title of most-watched television network ...
NEW YORK, New York - U.S. and global stocks tumbled Wednesday as lawmakers continued to navigate their way through Congress ...
The Pentagon's inspector general has found that equipment stockpiled in Kuwait hadn?t been properly maintainedSome of the weaponry that the ...
New Delhi [India], June 2 (ANI): The All India Women's Selection Committee on Friday announced the India 'A' (Emerging) squad ...
Washington [US], June 2 (ANI): In hospitalised patients, blood pressure is routinely monitored. Severe hypertension can cause a heart attack, ...
Madrid [Spain], June 2 (ANI): Real Madrid's maestro Karim Benzema received the Marca Leyenda (legend) award in recognition of his ...
New Delhi [India], June 2 (ANI): Former West Indies skipper Carl Hooper is set to join the West Indies team ...
BEIJING, June 2 (Xinhua) -- The following are the central parity rates of the Chinese currency renminbi, or the yuan, ...